Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,61 USD | -7,98% | -5,00% | -3,57% |
Omzet 2024 * | - | Omzet 2025 * | 13,5 mln. 12,64 mln. | Marktkapitalisatie | 110 mln. 103 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -59 mln. -55,25 mln. | Nettowinst (verlies) 2025 * | -82 mln. -76,79 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 8,13 x |
K/w-verhouding 2024 * |
-1,52
x | K/w-verhouding 2025 * |
-1,13
x | Werknemers | 47 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,37% |
Recentste transcriptie over Milestone Pharmaceuticals Inc.
1 dag | -0,57% | ||
1 week | +4,79% | ||
Lopende maand | -2,23% | ||
1 maand | +20,69% | ||
3 maanden | +16,67% | ||
6 maanden | -39,45% | ||
Lopend jaar | +4,79% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Oliveto
CEO | Chief Executive Officer | 56 | 07-03-17 |
Amit Hasija
DFI | Director of Finance/CFO | 51 | 09-09-19 |
Anita Holz
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Seth Fischer
BRD | Director/Board Member | 68 | 21-03-23 |
Joseph Oliveto
CEO | Chief Executive Officer | 56 | 07-03-17 |
Debra Liebert
BRD | Director/Board Member | 67 | 01-06-15 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 1,61 | -7,98% | 176 163 |
17-04-24 | 1,75 | -0,57% | 112 732 |
16-04-24 | 1,76 | +0,28% | 233 836 |
15-04-24 | 1,755 | +1,45% | 259 470 |
12-04-24 | 1,73 | +2,06% | 116 946 |
uitgestelde koers Nasdaq, 17 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,79% | 110 mln. | |
-3,39% | 102 mld. | |
+2,61% | 96,84 mld. | |
-1,11% | 21,48 mld. | |
-18,14% | 20,82 mld. | |
-7,31% | 18,6 mld. | |
-40,70% | 16,81 mld. | |
-26,89% | 13,78 mld. | |
+1,12% | 13,4 mld. | |
+22,25% | 11,06 mld. |